Bio-Rad Laboratories (BIO) Total Current Liabilities (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Total Current Liabilities of $917.0 million for Q1 2026, up 81.01% year-over-year from $506.6 million in Q1 2025, and up 77.37% quarter-over-quarter from $517.0 million in Q4 2025.
Bio-Rad Laboratories (BIO) Total Current Liabilities (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Total Current Liabilities for 18 consecutive years, with $917.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 81.01% year-over-year to $917.0 million; the TTM figure through Mar 2026 stood at $917.0 million (up 81.01% YoY), while the FY2025 annual figure was $517.0 million, up 10.52% from the prior year.
- Total Current Liabilities grew to $917.0 million in Q1 2026 per BIO's latest filing, from $517.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $917.0 million in Q1 2026 and bottomed at $466.2 million in Q1 2024.
- Historically, Total Current Liabilities has averaged $563.8 million across 5 years, with a median of $548.9 million in 2025.
- Annual changes were most pronounced in 2024 — Total Current Liabilities retreated 20.94% — and 2026, when it jumped 81.01%.
- Bio-Rad Laboratories' Total Current Liabilities stood at $568.7 million in 2022, then retreated by 8.07% to $522.8 million in 2023, then fell by 10.52% to $467.8 million in 2024, then gained by 10.52% to $517.0 million in 2025, then surged by 77.37% to $917.0 million in 2026.
- Business Quant data shows BIO's Total Current Liabilities at $917.0 million in Q1 2026, $517.0 million in Q4 2025, and $522.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Bio-Rad Laboratories | 10.10 Bn | 8.49 Bn | 345.80 Mn | 961.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 961.30 Mn |
| Mar 31, 2026 | 917.00 Mn |
| Dec 31, 2025 | 517.00 Mn |
| Sep 30, 2025 | 522.30 Mn |
| Jun 30, 2025 | 548.90 Mn |
| Mar 31, 2025 | 506.60 Mn |
| Dec 31, 2024 | 467.80 Mn |
| Sep 30, 2024 | 497.94 Mn |
| Jun 30, 2024 | 486.96 Mn |
| Mar 31, 2024 | 466.15 Mn |
| Dec 31, 2023 | 522.80 Mn |
| Sep 30, 2023 | 558.18 Mn |
| Jun 30, 2023 | 581.98 Mn |
| Mar 31, 2023 | 589.62 Mn |
| Dec 31, 2022 | 568.71 Mn |
| Sep 30, 2022 | 570.68 Mn |
| Jun 30, 2022 | 613.71 Mn |
| Mar 31, 2022 | 648.33 Mn |
| Dec 31, 2021 | 680.94 Mn |
| Sep 30, 2021 | 649.92 Mn |